Cybin Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, HELP reported earnings of -1.62 USD per share (EPS) for Q2 26, missing the estimate of -0.97 USD, resulting in a -67.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.68 USD, with revenue projected to reach -- USD, implying an decrease of -58.02% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Cybin Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Cybin Inc. Common Stock reported EPS of -$1.62, missing estimates by -67.47%, and revenue of $0.00, 0% as expectations.
How did the market react to Cybin Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Cybin Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 17, 2026.
What are the forecasts for Cybin Inc. Common Stock's next earnings report?
Based on 5
analysts, Cybin Inc. Common Stock is expected to report EPS of -$0.68 and revenue of -- for Q3 2026.